Author:
Qi Qiufeng,Peng Yun,Zhu Ming,Zhang Yaping,Bao Yanqing,Zhang Xiaobin,Zhang Jianqing,Liu Yongping
Subject
Pharmacology,Immunology,Immunology and Allergy
Reference41 articles.
1. H. Sung, et al., Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries, CA Cancer J Clin. 71 (3) (2021 May) 209–249, https://doi.org/10.3322/caac.21660.
2. A, Z., et al., Gastric cancer: French intergroup clinical practice guidelines for diagnosis. Dig Liver Dis, 2018. Aug;50(8):768-779. https://doi.org/10.1016/j.dld.2018.04.025.
3. A, D. and W. AD, Advanced gastric cancer: Current treatment landscape and future perspectives. World J Gastroenterol. 2016 Feb 28;22(8):2403-14. https://doi.org/ 10.3748/wjg.v22.i8.2403.
4. YY, J., et al., First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021 Jul 3;398(10294):27-40. https://doi.org/ 10.1016/S0140-6736(21)00797-2.
5. Fuchs CS, et al., Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer: Phase 2 Clinical KEYNOTE-059 Trial. JAMA Oncol. 2018 May 10;4(5):e180013. https://doi.org/ 10.1001/jamaoncol.2018.0013. Epub 2018 May 10.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献